4142 — Adimmune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Adimmune, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,891	2,973	2,470	2,457	2,218
Net Total Accounts Receivable
Net Total Receivables	99.6	535	1,308	188	147
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,796	4,491	4,699	3,610	3,271
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,575	3,848	3,976	4,087	4,160
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	8,010	9,149	9,484	8,481	8,193
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	297	500	1,787	1,161	1,546
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	1,861	3,025	4,010	3,249	3,248
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	6,149	6,124	5,475	5,233	4,944
Total Liabilities & Shareholders' Equity	8,010	9,149	9,484	8,481	8,193
Total Common Shares Outstanding